Home / News

News

Invectys AT BIO-Europe Spring 2019, Vienna March 25th 2...

BIO-Europe Spring 2019 March 25th – 27th 2019 Messe Wien Exhibition and Congress Center, Vienna, Austria Invectys will be attending the BIO-Europe Spring 2019.…

Read more

Invectys at the AACR meeting in Atlanta, March 2019

Invectys will be attending the AACR Annual Meeting 2019, March 29 – Apr 3, 2019. Georgia World Congress Center Atlanta,  The AACR (American Association for…

Read more

Invectys secures €15 million equity financing

Invectys secures €15 million equity financing to advance lead program INVAC-1 into groundbreaking phase II clinical trial in CLL   Financing complements the…

Read more

Invectys at JP Morgan 37th Annual Healthcare Conference...

January 7 – 10, 2019 J.P. Morgan 37th Annual Healthcare Conference 2019 San-Francisco   The annual J.P. Morgan Healthcare Conference is the largest and most…

Read more

FDA approval to launch INVAC-1 Phase II clinical trial

Invectys announces FDA approval to launch a Phase II clinical trial of its therapeutic cancer vaccine INVAC-1 After a recent capital raise of 4.3 M€s another…

Read more

4,3 Millions d’Euros de levés pour initier la Phase II

After its Phase I success, Invectys raises €4.3 million to enter Phase II with both of its anti-cancer vaccines   Paris, July 12th, 2017 – This round brings…

Read more

Invectys presents its INVAC-1 therapeutic vaccine Phase...

Presentation of the Invectys clinical trial results on cancer patients at the most important worldwide oncology meeting taking place this year in Chicago, USA Paris,…

Read more

BIO€QUITY Europe, Paris May 22, 23

Invectys will attend to the 18th annual BIO€QUITY Europe Meet Invectys there ! More information:  invest@invectys.com 18TH ANNUAL BIO€QUITY EUROPE Bio€quity…

Read more